A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
Clinical trial NCT06747156 · RECRUITING
Trial details
- NCT number
- NCT06747156
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-23
- Primary completion
- 2027-11-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.